Report Description

The global genomics market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include growing specialized medicines and wide application of genomics in numerous areas. Genomics is the branch of science that concerned with the structure, function, evolution, and mapping of genomes. Various steps are taken such as sampling, sequencing, data analysis and interpretation procedures to decode, assemble, and analyze genomes. Nowadays, people are diagnosed with genetic as well as chronic diseases due to which demand for personalized medicine is surging, which is bolstering the growth of the market. The other factors supporting the market's growth are, advancement in diagnostic techniques, increasing investments by governments, surge in cancer incidents and rise in R&D initiatives.

Increasing Demand of Specialized/Personalized Medicine

Growing importance of specialized medicines is one of the primary factors, supporting the growth of genomics market. The ability to advance health care facilities by providing unique clinical, genetic, genomic, and environmental information is increasing the importance of genomics. Surging demand of Personalized medicines is due to their efficiency to treat unique, yet complex diseases. They help medical researchers to identify the exact requirement of patient and then treat them accordingly. Based on the 2020 Scope and Significance of Progress report, personalized medicines accounted for around 39 percent of the total FDA-approved new drugs in the year. Doctors, researchers, and pharmaceutical firms are using precision medicine for developing new drug and disease therapies, and unique clinical testing. Personalized medicine uses all genes in human genome for identification, prevention, and treatment of any complex disease

Growing Application of Genomics in Various Sectors.

The use of genomics concepts in the field of synthetic biology, healthcare, study gene sequences of plants and organisms, and bioengineering sectors are some of the applications, which is anticipating the growth of the market. For instance, agricultural genomics is a field that is contributing to advances in crop development such as it can lessen the trials and failures involved in scientific research to a certain extent, which could enhance the quality and quantity of crop yields in agriculture. In December 2020, Calyxt, Inc. announced signing a research collaboration with NRGene Ltd. that comprises the use of the cloud-based genomic platform of NRGene to fast-track hemp trait discovery.

Technological Advancements

Rapid advancements and innovations in the genomics sector are bolstering the growth of the market. The advent of cheaper nucleic acid sequencing is modifying DNA and RNA on demand. Sensing the increasing demand several companies are offering sequencing services for nutrition, ancestry, and genetic diseases. Rapid advances in microscopy are also in process. For instance, in 2019, Thermo Fisher Scientific, Inc. (US) introduced the Oncomine Precision Assay, an innovative pan-cancer panel, for its Genexus platform to advance precision medicine in clinical settings. Other factors, such as massive research and development (R&D) activities in the bioinformatics sector and the increasing demand for next-generation sequencing services, are anticipating the growth of the market.


Download Free Sample Report

Market Segmentation

The global genomics market is segmented into products & services, technology, application, end user, and company. Based on products & services, the market is divided into systems & software, consumables, and service. Based on technology, the market is divided into sequencing, PCR, nucleic acid extraction and purification, microarray, and others. Based on application, the market is segmented into drug discovery & development, diagnostics, agriculture & animal research, and others. Based on end user, the market is divided into hospitals & clinics, academic & research institutions, biotechnology & pharmaceutical companies, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising importance of personalized medicines and wide application of genomics in the country.

Market Players

Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., 23andMe, Inc., Eppendorf AG, and Quest Diagnostics Inc. are some of the leading companies operating in the market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

·         Products & Services

·         Technology

·         Application

·         End User

·         Company

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa

Key companies profiled

Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., 23andMe, Inc., Eppendorf AG, and Quest Diagnostics Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, global genomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Genomics Market, By Products & Services:

    • Systems & Software
    • Consumables
    • Service    

·         Genomics Market, By Technology:

    • Sequencing
    • PCR
    • Nucleic Acid Extraction and Purification
    • Microarray
    • Others

·         Genomics Market, By Application:

    • Drug Discovery & Development
    • Diagnostics
    • Agriculture & Animal Research
    • Others

·         Genomics Market, By Application:

o    Hospitals & Clinics

o    Academic & Research Institutions

o    Biotechnology & Pharmaceutical Companies

o    Others

·         Genomics Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe & CIS
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Genomics Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Genomics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Genomics Market

4.    Voice of Customer

5.    Executive Summary

6.    Global Genomics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Products & Services (Systems & Software, Consumables, Service)

6.2.2.     By Technology (Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, Others)

6.2.3.     By Application (Drug Discovery & Development, Diagnostics, Agriculture & Animal Research, Others)

6.2.4.     By End User (Hospitals & Clinics, Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others)

6.2.5.     By Company (2021)

6.2.6.     By Region

6.3.  Market Map

7.    North America Genomics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Products & Services

7.2.2.     By Technology

7.2.3.     By Application

7.2.4.     By End User

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Genomics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product & Services

7.3.1.2.2.             By Technology

7.3.1.2.3.             By Application

7.3.1.2.4.             By End User

7.3.2.     Mexico Genomics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product & Services

7.3.2.2.2.             By Technology

7.3.2.2.3.             By Application

7.3.2.2.4.             By End User

7.3.3.     Canada Genomics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product & Services

7.3.3.2.2.             By Technology

7.3.3.2.3.             By Application

7.3.3.2.4.             By End User

8.    Europe Genomics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Products & Services

8.2.2.     By Technology

8.2.3.     By Application

8.2.4.     By End User

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Genomics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product & Services

8.3.1.2.2.             By Technology

8.3.1.2.3.             By Application

8.3.1.2.4.             By End User

8.3.2.     Germany Genomics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product & Services

8.3.2.2.2.             By Technology

8.3.2.2.3.             By Application

8.3.2.2.4.             By End User

8.3.3.     United Kingdom Genomics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product & Services

8.3.3.2.2.             By Technology

8.3.3.2.3.             By Application

8.3.3.2.4.             By End User

8.3.4.     Italy Genomics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product & Services

8.3.4.2.2.             By Technology

8.3.4.2.3.             By Application

8.3.4.2.4.             By End User

8.3.5.     Spain Genomics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product & Services

8.3.5.2.2.             By Technology

8.3.5.2.3.             By Application

8.3.5.2.4.             By End User

9.    Asia-Pacific Genomics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Products & Services

9.2.2.     By Technology

9.2.3.     By Application

9.2.4.     By End User

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Genomics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product & Services

9.3.1.2.2.             By Technology

9.3.1.2.3.             By Application

9.3.1.2.4.             By End User

9.3.2.     India Genomics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product & Services

9.3.2.2.2.             By Technology

9.3.2.2.3.             By Application

9.3.2.2.4.             By End User

9.3.3.     Japan Genomics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product & Services

9.3.3.2.2.             By Technology

9.3.3.2.3.             By Application

9.3.3.2.4.             By End User

9.3.4.     South Korea Genomics Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Product & Services

9.3.4.2.2.             By Technology

9.3.4.2.3.             By Application

9.3.4.2.4.             By End User

9.3.5.     Australia Genomics Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Product & Services

9.3.5.2.2.             By Technology

9.3.5.2.3.             By Application

9.3.5.2.4.             By End User

10.  South America Genomics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Products & Services

10.2.2.  By Technology

10.2.3.  By Application

10.2.4.  By End User

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Genomics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product & Services

10.3.1.2.2.           By Technology

10.3.1.2.3.           By Application

10.3.1.2.4.           By End User

10.3.2.  Argentina Genomics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product & Services

10.3.2.2.2.           By Technology

10.3.2.2.3.           By Application

10.3.2.2.4.           By End User

10.3.3.  Colombia Genomics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product & Services

10.3.3.2.2.           By Technology

10.3.3.2.3.           By Application

10.3.3.2.4.           By End User

11.  Middle East and Africa Genomics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Products & Services

11.2.2.  By Technology

11.2.3.  By Application

11.2.4.  By End User

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Genomics Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Product & Services

11.3.1.2.2.           By Technology

11.3.1.2.3.           By Application

11.3.1.2.4.           By End User

11.3.2.  Saudi Arabia Genomics Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Product & Services

11.3.2.2.2.           By Technology

11.3.2.2.3.           By Application

11.3.2.2.4.           By End User

11.3.3.  UAE Genomics Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Product & Services

11.3.3.2.2.           By Technology

11.3.3.2.3.           By Application

11.3.3.2.4.           By End User

11.3.4.  Egypt Genomics Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Product & Services

11.3.4.2.2.           By Technology

11.3.4.2.3.           By Application

11.3.4.2.4.           By End User

11.3.5.  Turkey Genomics Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Product & Services

11.3.5.2.2.           By Technology

11.3.5.2.3.           By Application

11.3.5.2.4.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Illumina, Inc.

14.2.              Thermo Fischer Scientific, Inc.

14.3.              QIAGEN N.V.

14.4.              Agilent Technologies, Inc.

14.5.              F. Hoffmann-La Roche AG

14.6.              Bio-Rad Laboratories, Inc.

14.7.              Eurofins Scientific SE

14.8.              Oxford Nanopore Technologies Limited

14.9.              Pacific Biosciences of California, Inc.

14.10.            Danaher Corporation

14.11.            GE Healthcare

14.12.            Myriad Genetics, Inc.

14.13.            23andMe, Inc.

14.14.            Eppendorf AG

14.15.            Quest Diagnostics Inc.

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Growing specialized medicines and wide application of genomics in numerous areas are driving the demand for the global genomics market.

down-arrow

Illumina, Inc., Thermo Fischer Scientific, Inc., QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., 23andMe, Inc., Eppendorf AG, and Quest Diagnostics Inc. are the key players operating in the global genomics market.

down-arrow

The high cost of genomic equipment and lack of education about genomics are likely to hinder the growth of market. Additionally, stringent regulatory framework to develop new products is likely to hamper the growth of the market.

down-arrow

The Global Genomics Market is studied from 2017 to 2027.